ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-Positive|HER2-Negative|Locally Advanced Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: ZB716|DRUG: Palbociclib
Sponsor: EnhancedBio USA Inc.
Collaborators: Zenopharm